Jennison Associates’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-2,613,159
| Closed | -$7.03M | – | 678 |
|
2016
Q1 | $7.03M | Buy |
2,613,159
+15,291
| +0.6% | +$41.1K | 0.01% | 471 |
|
2015
Q4 | $8.03M | Buy |
2,597,868
+3,912
| +0.2% | +$12.1K | 0.01% | 488 |
|
2015
Q3 | $11.5M | Sell |
2,593,956
-36,986
| -1% | -$163K | 0.01% | 492 |
|
2015
Q2 | $15M | Buy |
2,630,942
+15,948
| +0.6% | +$91.1K | 0.01% | 480 |
|
2015
Q1 | $23.4M | Buy |
+2,614,994
| New | +$23.4M | 0.02% | 427 |
|
2014
Q4 | – | Sell |
-12,436
| Closed | -$89K | – | 796 |
|
2014
Q3 | $89K | Buy |
+12,436
| New | +$89K | ﹤0.01% | 712 |
|